Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 4
2009 3
2010 4
2011 4
2012 3
2013 5
2014 2
2016 5
2017 3
2018 1
2019 1
2021 2
2022 3
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Dexamethasone and Surgical-Site Infection.
Corcoran TB, Myles PS, Forbes AB, Cheng AC, Bach LA, O'Loughlin E, Leslie K, Chan MTV, Story D, Short TG, Martin C, Coutts P, Ho KM; PADDI Investigators; Australian and New Zealand College of Anaesthetists Clinical Trials Network; Australasian Society for Infectious Diseases Clinical Research Network. Corcoran TB, et al. N Engl J Med. 2021 May 6;384(18):1731-1741. doi: 10.1056/NEJMoa2028982. N Engl J Med. 2021. PMID: 33951362 Clinical Trial.
Exploitation of Dunaliella for beta-carotene production.
Raja R, Hemaiswarya S, Rengasamy R. Raja R, et al. Among authors: rengasamy r. Appl Microbiol Biotechnol. 2007 Mar;74(3):517-23. doi: 10.1007/s00253-006-0777-8. Epub 2007 Jan 16. Appl Microbiol Biotechnol. 2007. PMID: 17225103 Review.
A perspective on the biotechnological potential of microalgae.
Raja R, Hemaiswarya S, Kumar NA, Sridhar S, Rengasamy R. Raja R, et al. Among authors: rengasamy r. Crit Rev Microbiol. 2008;34(2):77-88. doi: 10.1080/10408410802086783. Crit Rev Microbiol. 2008. PMID: 18568862 Review.
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort.
Thiruvengadam R, Ayushi, Murugesan DR, Desiraju BK, Misra S, Sharma D, Subbaian SS, Mehta U, Singh A, Sharma S, Khurana A, Mittal P, Chellani H, Bharti R, Tripathi R, Sopory S, Kshetrapal P, Salunke DM, Natchu UCM, Ramji S; GARBH-Ini study team; Wadhwa N, Bhatnagar S. Thiruvengadam R, et al. Lancet Glob Health. 2024 Aug;12(8):e1261-e1277. doi: 10.1016/S2214-109X(24)00212-2. Lancet Glob Health. 2024. PMID: 39030058 Free article.
Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.
Choi YJ, Kim DS, Sung YH, Kim DH, Im K, Lee H, Lee CW, Cho J, Min J, Woo DC, Kim SE, Lee S, Kong YJ, Ryu HC, Kim JS, Rengasamy R, Ji W, Choi CM, Lee JC, Rho JK. Choi YJ, et al. Among authors: rengasamy r. Cancer Res. 2022 Aug 26:OF1. doi: 10.1158/0008-5472.CAN-22-2507. Online ahead of print. Cancer Res. 2022. PMID: 36018295 No abstract available.
The reversible fourth-generation EGFR tyrosine kinase inhibitor OBX02-011 overcomes C797S-mediated resistance in lung cancer.
Choi YJ, Kim DS, Hoon Sung Y, Kim DH, Im K, Lee H, Lee CW, Cho J, Min J, Woo DC, Kim SE, Lee S, Kong YJ, Ryu HC, Kim JS, Rengasamy R, Ji W, Choi CM, Lee JC, Rho JK. Choi YJ, et al. Among authors: rengasamy r. Cancer Res. 2022 Jun 14:canres.0394.2022-2-3 21:03:12.200. doi: 10.1158/0008-5472.CAN-22-0394. Online ahead of print. Cancer Res. 2022. Retraction in: Cancer Res. 2022 Aug 26:OF1. doi: 10.1158/0008-5472.CAN-22-2507 PMID: 35700239 Retracted.
Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer.
Choi YJ, Kim DS, Sung YH, Kim DH, Im K, Lee H, Lee CW, Cho J, Min J, Woo DC, Kim SE, Lee S, Kong YJ, Ryu HC, Kim JS, Rengasamy R, Ji W, Choi CM, Lee JC, Rho JK. Choi YJ, et al. Among authors: rengasamy r. Cancer Res. 2022 Aug 25:OF1. doi: 10.1158/0008-5472.CAN-22-2377. Online ahead of print. Cancer Res. 2022. PMID: 36006687 No abstract available.
37 results